Streetbeat News

Stock Prices

NVDA

NVIDIA's stock price increased following UBS's decision to maintain a Buy rating and raise its price target from $800 to $1,100.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:04 pm

ICPUSD

Internet Computer's (CRYPTO: ICP) price has increased by 12.54% in the last 24 hours, reaching $13.68. This marks a continuation of its positive trend, with a 4.0% gain over the past week from $13.15. The coin's all-time high is $700.65. Trading volume for ICP has risen by 19.0% over the past week, while the circulating supply has slightly decreased by 0.07%, totaling 461.16 million. ICP's current market cap ranking is #23, valued at $6.29 billion.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 7:03 pm

TRXUSD

TRON (CRYPTO: TRX) has seen a 3.12% decrease in price over the last 24 hours, continuing a negative trend with an 8.0% loss over the past week. The trading volume and circulating supply have also decreased, with the market cap ranking at #16.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 7:02 pm

ABSI

Six analysts have recently assessed Absci (NASDAQ:ABSI), showing a mix of bullish and somewhat bullish ratings with an average 12-month price target of $8.17, a significant increase from the previous $4.00. Absci, an AI-powered synthetic biology company, has seen a revenue decline of -68.59% over the past 3 months, with a net margin of -2956.18%, ROE of -10.68%, and ROA of -8.97%. Despite the financial challenges, the company's market position remains strong with a low debt-to-equity ratio of 0.09.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 7:01 pm

CVS

Financial analysts have observed a mix of bullish and bearish options trading activity on CVS Health (NYSE:CVS), with significant trades indicating a price target range between $70.0 and $82.5. The analysis of options trades, including both calls and puts, suggests a cautious market sentiment towards CVS Health. Despite this, CVS Health's stock is currently up by 0.59%, trading at $78.73, with expert opinions offering a higher average target price of $86.67. The company's diverse healthcare services and recent acquisition of Oak Street highlight its potential for synergy and growth.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 7:01 pm

XRPUSD

XRP (CRYPTO: XRP) has seen a 3.27% decrease in price over the last 24 hours, continuing a negative trend with a 5.0% loss over the past week. The trading volume has decreased by 38.0%, while the circulating supply increased slightly by 0.04%. XRP's market cap ranking is currently #6 at $33.61 billion.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 7:00 pm

DRI

Darden Restaurants Inc (NYSE:DRI) reported Q3 FY24 sales of $2.975 billion, missing estimates, with a 6.8% Y/Y growth. Adjusted EPS was $2.62, in line with expectations. FY24 sales forecast was revised to $11.4 billion from $11.5 billion, with same-restaurant sales growth expectations lowered to 1.5%-2%. Following the earnings announcement, analysts from Citigroup, JP Morgan, Morgan Stanley, Wedbush, and Oppenheimer adjusted their price targets on DRI, all maintaining positive ratings but lowering their price targets. DRI shares rose 0.9% to $164.75.

Portfolio Pulse from Avi Kapoor

March 22, 2024 | 6:58 pm

ARKK

COIN

SARK

Coinbase Global, Inc (NASDAQ:COIN) reached a 27-month high of $276.38, showing strength despite a retracement in Bitcoin and Ethereum. JMP analyst Devin Ryan maintained a $300 price target for Coinbase, highlighting its growth prospects. Meanwhile, Ark Invest sold 199,526 Coinbase shares through ARKK, ARKW, and ARKF. Traders bearish on ARKK may consider SARK, which shorts disruptive innovation. Coinbase's stock is forming a potential bull flag pattern, indicating a possible uptrend towards $318.

Portfolio Pulse from Melanie Schaffer

March 22, 2024 | 6:54 pm

CUTR

IDN

ISPR

LULU

SINT

SMLP

U.S. stocks traded mixed with the Nasdaq Composite up by 0.3%. Lululemon's shares plummeted over 15% after issuing a weak Q1 forecast despite better-than-expected Q4 results. Summit Midstream Partners surged 38% after announcing a $625 million sale of its Utica position. Intellicheck's shares rose 70% following a year-over-year increase in Q4 EPS. Cutera, Sintx Technologies, and Ispire Technology saw significant drops after disappointing financial results and public offering announcements.

Portfolio Pulse from Avi Kapoor

March 22, 2024 | 6:50 pm